This makes it easier to buy and sell these assets, opening up opportunities that used to be out of reach for most people. Clover’s focus on playing by the rules and building solutions also shows ...

Clover Health shares are climbing on heavy trading volume following the insider buy. According to data from Benzinga Pro, more than 10.8 million shares have already been traded in Friday's session ...

As previously reported, Craig-Hallum initiated coverage of Clover Health (CLOV) with a Buy rating and $6 price target The firm believes Clover Health is a disrupter in the physician enablement and ...

On Tuesday, Clover Health (NASDAQ:CLOV) shares received a positive outlook from Craig-Hallum, as the firm started coverage on the company's stock with a Buy rating and set a price target of $6.00 ...